网站主页 >> CAS数据库列表 >> TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
|
|
|
- CAS号:
- 383415-79-0
- 英文名:
- H-TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-OH
- 英文别名:
- NPW-23 (HUMAN);NEUROPEPTIDE W-23 (HUMAN);Neuropeptide W-23 (human) TFA;Neuropeptide W-23 (huMan)
NPW-23 (huMan);Neuropeptide W-23(human),WYKHVASPRYHTVGRAAGL MGL,NPW-23, >95%;TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU;H-TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-OH;Neuropeptide W23(human),hypetension,anorexigenic effect,Neuropeptide W 23(human),Neuropeptide W-23 (human),NPW 23,GPR7,Inhibitor,Neuropeptide W,GPR8,NPBW1,NPBW2,inhibit,NPW23;L-Leucine, L-tryptophyl-L-tyrosyl-L-lysyl-L-histidyl-L-valyl-L-alanyl-L-seryl-L-prolyl-L-arginyl-L-tyrosyl-L-histidyl-L-threonyl-L-valylglycyl-L-arginyl-L-alanyl-L-alanylglycyl-L-leucyl-L-leucyl-L-methionylglycyl-
- 中文名:
- TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
- 中文别名:
- 神经肽 W-23 (人);神经肽W-23(人类)三氟乙酸盐;神经肽W-23(人类) TFA盐;神经肽 W-23 (人), >95%;化合物NEUROPEPTIDE W-23(HUMAN);神经肽W NEURO PEPTIDE W-23 (HUMAN)
- CBNumber:
- CB3154841
- 分子式:
- C119H183N35O28S
- 分子量:
- 2584.01
- MOL File:
- 383415-79-0.mol
|
|
|
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU化学性质
-
储存条件:
-
Desiccate at -20°C
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to off-white
-
|
-
水溶解性:
-
Soluble to 1 mg/ml in sterile water
-
|
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU性质、用途与生产工艺
Neuropeptide W-23(human) 是 Neuropeptide W 的主要活性形式，为 NPBW1 和 NPBW2 的内源性配体。
NPW-23 increases the I
Ca,L
in transfected human embryonic kidney 293 cells and VSMCs via GPR7. NPW-23 increases the expression of pan phospho-PKC, intracellular diacylglycerol level, and the second messenger catalyzed by PLC.
NPW-23 increases pressure-induced vasotone of the rat mesenteric arteries. Importantly, the expression of NPW is decreased in the hypertensive rats. NPW-23 (0.3 nmol, 1.0 nmol, and 3.0 nmol) induces significant increases in mean arterial pressure (MAP) in conscious, freely moving male rats. Rats that receive either 1.0 or 3.0 nmol NPW-23 demonstrate a significant increase in total activity, ambulatory activity, and duration of stereotypy. NPW-23 fails to elevate MAP in rats pretreated with phentolamine. NPW-23-induced increases in total activity, ambulatory activity, and duration of stereotypy are reduced significantly by pretreatment with the orexin type 1 receptor (OX1R) antagonist, SB-408124.
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/11/08 | HY-P1035 | TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
Neuropeptide W-23(human) | 383415-79-0 | 1mg | 1500元 |
| 2024/11/08 | HY-P1035 | TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
Neuropeptide W-23(human) | 383415-79-0 | 5mg | 4500元 |
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
生产厂家
383415-79-0, TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU 相关搜索:
GIP(3-42),human 丝肽蛋白 神经肽W-30(人) NEUROPEPTIDEY(3-36)(HUMAN,RAT) NEUROPEPTIDEY(13-36)(HUMAN,RAT) LEU-ALA-HIS-GLN-ILE-TYR-GLN-PHE-THR-ASP-LYS-ASP-LYS-ASP-ASN-VAL-ALA-PRO-ARG-SER-LYS-ILE-SER-PRO-GLN-GLY-TYR-NH2 乙酰丙酮银 异腈基乙酸甲酯 乙酰丙酮酸铜 苄异腈 异氰酸叔丁酯 1,1,3,3-四甲基丁基异氰 2,2,6,6-四甲基-3,5-庚烷二酸镝 乙二胺氯化铂 双水杨酰胺乙基钴 三乙酰丙酮铝 乙酰丙酮铬盐 三(2,2,6,6-四甲基-3,5-庚二酸)铕
- Various peptides
- 抑制剂
- 药靶配体
- 标准品
- C119H183N35O28S
- 神经肽W-23(人类)三氟乙酸盐
- 神经肽W NEURO PEPTIDE W-23 (HUMAN)
- 神经肽W-23(人类) TFA盐
- 化合物NEUROPEPTIDE W-23(HUMAN)
- 神经肽 W-23 (人)
- 神经肽 W-23 (人), >95%
- 383415-79-0
- Neuropeptide W-23 (human) TFA
- Neuropeptide W23(human),hypetension,anorexigenic effect,Neuropeptide W 23(human),Neuropeptide W-23 (human),NPW 23,GPR7,Inhibitor,Neuropeptide W,GPR8,NPBW1,NPBW2,inhibit,NPW23
- Neuropeptide W-23(human),WYKHVASPRYHTVGRAAGL MGL,NPW-23, >95%
- L-Leucine, L-tryptophyl-L-tyrosyl-L-lysyl-L-histidyl-L-valyl-L-alanyl-L-seryl-L-prolyl-L-arginyl-L-tyrosyl-L-histidyl-L-threonyl-L-valylglycyl-L-arginyl-L-alanyl-L-alanylglycyl-L-leucyl-L-leucyl-L-methionylglycyl-
- Neuropeptide W-23 (huMan)
NPW-23 (huMan)
- TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
- NEUROPEPTIDE W-23 (HUMAN)
- NPW-23 (HUMAN)
- H-TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-OH